Substance / Medication

Lormetazepam

Overview

Active Ingredient
lormetazepam
RxNorm CUI
28894

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Role of lormetazepam in the treatment of insomnia in the elderly.
De Vanna Maurizio, Rubiera Marta, Onor Maria Luisa et al. · Clin Drug Investig · 2007
PMID: 17451280RCT
Focal bilateral motor seizures precipitated by abrupt cessation of chronic lormetazepam abuse and amitriptyline overdose.
Rossi Rosario, Di Stefano Francesca, Lizzos Sara et al. · Epilepsy Behav Rep · 2021
PMID: 33490945Case ReportFull text (PMC)
Pharmacokinetics of Enteral Lormetazepam in Mechanically Ventilated ICU Patients with COVID-19: An Adjunct Sedative Study.
le Noble Jos L M L, Shudofsky Kimberly N, Foudraine Norbert et al. · Clin Pharmacokinet · 2024
PMID: 39546269OtherFull text (PMC)
Can oral formulation increase the risk of lormetazepam abuse?
Costa Enrico, Sterzi Enrico, Tedeschi Federico et al. · Intern Emerg Med · 2021
PMID: 33095413Other
Outcomes in Critically Ill Patients Sedated with Intravenous Lormetazepam or Midazolam: A Retrospective Cohort Study.
Weiss Björn, Hilfrich David, Vorderwülbecke Gerald et al. · J Clin Med · 2021
PMID: 34575204OtherFull text (PMC)
High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde-reply.
Tamburin Stefano, Lugoboni Fabio · Intern Emerg Med · 2020
PMID: 31471874Other
High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde-comment.
Ferini-Strambi Luigi, Sforza Marco, Galbiati Andrea · Intern Emerg Med · 2020
PMID: 31286409Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lormetazepam (substance)
SNOMED CT
387570005
UMLS CUI
C0065185
RxNorm CUI
28894

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

1
Conditions
2
Biomarkers
3
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.